Cisplatin shortage results in substitution of more expensive treatments: Drug cost analysis

Eur J Cancer. 2024 May:202:114019. doi: 10.1016/j.ejca.2024.114019. Epub 2024 Mar 16.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols
  • Cisplatin* / therapeutic use
  • Cost-Benefit Analysis
  • Costs and Cost Analysis
  • Humans
  • Lung Neoplasms* / drug therapy
  • Vinblastine

Substances

  • Cisplatin
  • Vinblastine